End-of-day quote
Shanghai S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
2.8
CNY
|
+1.08%
|
|
+4.09%
|
-23.50%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,051
|
2,660
|
1,989
|
3,275
|
2,740
|
2,923
|
Enterprise Value (EV)
1 |
2,452
|
2,177
|
1,635
|
2,884
|
2,331
|
2,513
|
P/E ratio
|
4.24
x
|
-1.42
x
|
125
x
|
103
x
|
172
x
|
40.7
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.52
x
|
7.11
x
|
18.6
x
|
25.7
x
|
19.5
x
|
20.6
x
|
EV / Revenue
|
1.22
x
|
5.82
x
|
15.3
x
|
22.7
x
|
16.6
x
|
17.7
x
|
EV / EBITDA
|
104
x
|
-4.34
x
|
137
x
|
132
x
|
102
x
|
112
x
|
EV / FCF
|
-6.91
x
|
124
x
|
-11.7
x
|
211
x
|
1,107
x
|
-181
x
|
FCF Yield
|
-14.5%
|
0.81%
|
-8.53%
|
0.47%
|
0.09%
|
-0.55%
|
Price to Book
|
1.39
x
|
7.01
x
|
5.06
x
|
7.75
x
|
6.27
x
|
5.75
x
|
Nbr of stocks (in thousands)
|
798,695
|
798,695
|
798,695
|
798,695
|
798,695
|
798,695
|
Reference price
2 |
3.820
|
3.330
|
2.490
|
4.100
|
3.430
|
3.660
|
Announcement Date
|
3/18/19
|
4/29/20
|
4/15/21
|
2/25/22
|
3/15/23
|
3/29/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
2,009
|
374
|
107.1
|
127.3
|
140.5
|
141.9
|
EBITDA
1 |
23.64
|
-501.6
|
11.95
|
21.93
|
22.89
|
22.48
|
EBIT
1 |
-210.1
|
-671.8
|
4.333
|
14.29
|
15.44
|
14.55
|
Operating Margin
|
-10.46%
|
-179.65%
|
4.04%
|
11.23%
|
10.99%
|
10.25%
|
Earnings before Tax (EBT)
1 |
481.5
|
-1,971
|
12.72
|
28.81
|
15.86
|
73.25
|
Net income
1 |
390.3
|
-1,867
|
12.72
|
28.81
|
15.86
|
73.25
|
Net margin
|
19.43%
|
-499.25%
|
11.87%
|
22.64%
|
11.29%
|
51.62%
|
EPS
2 |
0.9000
|
-2.340
|
0.0200
|
0.0400
|
0.0200
|
0.0900
|
Free Cash Flow
1 |
-355
|
17.55
|
-139.4
|
13.69
|
2.105
|
-13.91
|
FCF margin
|
-17.68%
|
4.69%
|
-130.11%
|
10.76%
|
1.5%
|
-9.8%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
62.44%
|
9.2%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
47.52%
|
13.28%
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/18/19
|
4/29/20
|
4/15/21
|
2/25/22
|
3/15/23
|
3/29/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
599
|
483
|
354
|
390
|
409
|
410
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-355
|
17.5
|
-139
|
13.7
|
2.11
|
-13.9
|
ROE (net income / shareholders' equity)
|
34%
|
-147%
|
3.29%
|
7.07%
|
3.69%
|
15.5%
|
ROA (Net income/ Total Assets)
|
-4.42%
|
-25.2%
|
0.51%
|
1.87%
|
1.93%
|
1.71%
|
Assets
1 |
-8,839
|
7,416
|
2,494
|
1,540
|
820.1
|
4,275
|
Book Value Per Share
2 |
2.740
|
0.4700
|
0.4900
|
0.5300
|
0.5500
|
0.6400
|
Cash Flow per Share
2 |
0.7900
|
0.6000
|
0.4400
|
0.4900
|
0.5100
|
0.5100
|
Capex
|
-
|
-
|
0.1
|
1.01
|
5.96
|
7.81
|
Capex / Sales
|
-
|
-
|
0.09%
|
0.79%
|
4.25%
|
5.5%
|
Announcement Date
|
3/18/19
|
4/29/20
|
4/15/21
|
2/25/22
|
3/15/23
|
3/29/24
|
|
1st Jan change
|
Capi.
|
---|
| -23.50% | 309M | | +5.14% | 103B | | -1.80% | 65.6B | | +39.52% | 39.06B | | +12.91% | 37.58B | | +7.41% | 33.26B | | +6.85% | 19.22B | | +12.86% | 16.83B | | +7.73% | 15.03B | | +16.93% | 14.96B |
Other Commodity Chemicals
|